Evaluation of peptide selection approaches for epitope-based vaccine design

Tissue Antigens

Volumn 82, Issue 4, 2013, Pages 243-251

  Schubert, B ^a   Lund, O ^b   Nielsen, M ^b,c  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^c INSTITUTO DE INVESTIGACIONES BIOTECNOLÓGICAS   (Argentina)

Author keywords

Epitope based vaccine design; HLA supertypes; Optimization; Peptide selection

Indexed keywords

EPITOPE; EPITOPE VACCINE; HLA A ANTIGEN; HLA B ANTIGEN; UNCLASSIFIED DRUG; VACCINE;

ALLELE; ARTICLE; BINDING AFFINITY; COMPARATIVE STUDY; COMPUTER MODEL; GENETIC ALGORITHM; HLA SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOGENICITY; MOSAICISM; PEPTIDE ANALYSIS; PRIORITY JOURNAL;

EPITOPE-BASED VACCINE DESIGN; HLA SUPERTYPES; OPTIMIZATION; PEPTIDE SELECTION;

AIDS VACCINES; ALGORITHMS; ALLELES; ANTIGENS, VIRAL; COMPUTER SIMULATION; EPITOPES, T-LYMPHOCYTE; GENE FREQUENCY; HIV INFECTIONS; HIV-1; HLA ANTIGENS; HOST-PATHOGEN INTERACTIONS; HUMANS; MODELS, IMMUNOLOGICAL; PEPTIDES; T-LYMPHOCYTES; VACCINES, SUBUNIT;

EID: 84890827806     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/tan.12199     Document Type: Article

References (33)

1. de Quadros CA. History and prospects for viral disease eradication. Med Microbiol Immunol 2002: 191: 75-81.
2. Vaughan A, Wang R, Kappe SH. Genetically engineered, attenuated whole-cell vaccine approaches for malaria. Hum Vaccin 2010: 6: 107-13.
3. Leroux-Roels I, Leroux-Roels G, Clement F et al. A phase 1/2 clinical trial evaluating safety and immunogenicity of a varicella zoster glycoprotein E subunit vaccine candidate in young and older adults. J Infect Dis 2012: 206: 1280-90.
4. Rittig SM, Haentschel M, Weimer KJ et al. Intradermal vaccinations with RNA coding for TAA generate CD8+; and CD4+; immune responses and induce clinical benefit in vaccinated patients. Mol Ther 2010: 19: 990-9.
5. Steele J, Rao A, Marsden J et al. Phase I/II trial of a dendritic cell vaccine transfected with DNA encoding melan A and gp100 for patients with metastatic melanoma. Gene Therapy 2011: 18: 584-93.
6. Purcell AW, McCluskey J, Rossjohn J. More than one reason to rethink the use of peptides in vaccine design. Nat Rev Drug Discov 2007: 6: 404-14.
7. Ishioka GY, Fikes J, Hermanson G et al. Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes. J Immunol 1999: 162: 3915-25.
8. Depil S, Moralès O, Castelli FA et al. Determination of a HLA II promiscuous peptide cocktail as potential vaccine against EBV latency II malignancies. J Immunother 2007: 30: 215-26.
9. Mateo L, Gardner J, Chen Q et al. An HLA-A2 polyepitope vaccine for melanoma immunotherapy. J Immunol 1999: 163: 4058-63.
10. Doan T, Herd K, Ramshaw I, Thomson S, Tindle RW. A polytope DNA vaccine elicits multiple effector and memory CTL responses and protects against human papillomavirus 16 E7-expressing tumour. Cancer Immunol Immunother 2005: 54: 157-71.
11. Schafer JRA, Jesdale BM, George JA, Kouttab NM, De Groot AS. Prediction of well-conserved HIV-1 ligands using a matrix-based algorithm, EpiMatrix. Vaccine 1998: 16: 1880-4.
12. De Groot AS, Marcon L, Bishop EA et al. HIV vaccine development by computer assisted design: the GAIA vaccine. Vaccine 2005: 23: 2136-48.
13. Zhang GL, Khan AM, Srinivasan KN et al. Hotspot Hunter: a computational system for large-scale screening and selection of candidate immunological hotspots in pathogen proteomes. BMC Bioinformatics 2008: 9 (Suppl 1): S19.
14. Vider-Shalit T, Raffaeli S, Louzoun Y. Virus-epitope vaccine design: informatic matching the HLA-I polymorphism to the virus genome. Mol Immunol 2007: 44: 1253-61.
15. Fischer W, Perkins S, Theiler J et al. Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants. Nat Med 2006: 13: 100-6.
16. Toussaint NC, Dönnes P, Kohlbacher O. A mathematical framework for the selection of an optimal set of peptides for epitope-based vaccines. PLoS Comput Biol 2008: 4: e1000246.
17. Toussaint NC, Kohlbacher O. OptiTope-a web server for the selection of an optimal set of peptides for epitope-based vaccines. Nucleic Acids Res 2009: 37 (suppl 2): W617-W622.
18. Toussaint NC, Maman Y, Kohlbacher O, Louzoun Y. Universal peptide vaccines-optimal peptide vaccine design based on viral sequence conservation. Vaccine 2011: 29: 8745-53.
19. Buggert M, Norström MM, Czarnecki C et al. Characterization of HIV-specific CD4+ T cell responses against peptides selected with broad population and pathogen coverage. PloS One 2012: 7: e39874.
20. Lundegaard C, Buggert M, Karlsson A, Lund O, Perez C, Nielsen M. PopCover: a method for selecting of peptides with optimal population and pathogen coverage. In: Proceedings of the First ACM International Conference on Bioinformatics and Computational Biology, 2010. ACM.
21. Stranzl T, Larsen MV, Lundegaard C, Nielsen M. NetCTLpan: pan-specific MHC class I pathway epitope predictions. Immunogenetics 2010: 62: 357-68.
22. Los Alamos National Labratory. Los Alamos HIV Sequence DB. http://www.hiv.lanl.gov/. Accessed August 2012.
23. WHO, Unaids, Unicef. Global HIV/AIDS response: epidemic update and health sector progress towards universal access. Progress report November. 2011.
24. Helmberg W. Bioinformatic databases and resources in the public domain to aid HLA research. Tissue Antigens 2012: 80: 295-304.
25. Lund O, Nielsen M, Kesmir C et al. Definition of supertypes for HLA molecules using clustering of specificity matrices. Immunogenetics 2004: 55: 797-810.
26. Hoof I, Peters B, Sidney J et al. NetMHCpan, a method for MHC class I binding prediction beyond humans. Immunogenetics 2009: 61: 1-13.
27. Llano A, Frahm N, Brander C. How to optimally define optimal cytotoxic T lymphocyte epitopes in HIV infection. HIV Mol Immunol 2009: 2009: 3-24.
28. Van Rossum G, Drake F.L. The Python Language Reference Manual. Bristol, UK: Network Theory Ltd, 2011.
29. Ascher D, Dubois PF, Hinsen K, Hugunin J, Oliphant T. Numerical python, 2001, Package to speed-up arithmetic operations on arrays of numbers, 1.6.2 ed. http://sourceforge.net/projects/numpy.
30. Perone CS. Pyevolve: a Python open-source framework for genetic algorithms. ACM SIGEVOlution 2009: 4: 12-20.
31. Makhorin A. GNU Linear Programming Kit, 4.47 ed: GNU Software Foundation, http://www.gnu.org/software/glpk/glpk.html
32. ILOG CPLEX, ILOG CPLEX Inc., 11.100 ed. (2005) http://www.ilog.com
33. R Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria, 2011. ISBN 3-900051-07-0